Agilon Health (NYSE:AGL) Issues Earnings Results, Beats Estimates By $3.20 EPS

Agilon Health (NYSE:AGL) issued its earnings results on Wednesday. The company reported $1.97 earnings per share for the quarter, topping analysts’ consensus estimates of ($1.23) by $3.20, FiscalAI reports. The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.46 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%.

Agilon Health Stock Up 8.9%

NYSE AGL traded up $7.83 on Wednesday, hitting $95.62. 277,309 shares of the company were exchanged, compared to its average volume of 319,459. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The company has a market cap of $1.61 billion, a PE ratio of -6.70 and a beta of 3.10. The stock has a fifty day moving average of $87.43 and a 200-day moving average of $65.50. Agilon Health has a 12 month low of $7.48 and a 12 month high of $133.04.

Wall Street Analyst Weigh In

AGL has been the subject of a number of research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th. JPMorgan Chase & Co. increased their price target on shares of Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a report on Monday, August 24th. Wells Fargo & Company restated an “overweight” rating and set a $146.00 price objective (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Robert W. Baird set a $116.00 price objective on Agilon Health in a report on Thursday, August 6th. Finally, Truist Financial set a $112.00 target price on Agilon Health and gave the company a “hold” rating in a research report on Thursday, August 6th. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $102.25.

Agilon Health Company Profile

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.